Miscellaneous ePI Test
0.1.0 - CI Build

Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions

: Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use - XML Representation

Raw xml | Download



<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="authsimvastatin20"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authsimvastatin20"> </a><a name="hcauthsimvastatin20"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;authsimvastatin20&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://pmda-approvalandlicenseno/</code>/21300AMY00128 (use: official)</p><p><b>subject</b>: <a href="MedicinalProductDefinition-medprodsimvastatin20.html">MedicinalProductDefinition/medprodsimvastatin20</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000072062)</span></p><p><b>region</b>: Japan <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#jp)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>holder</b>: <a href="Organization-orgohara.html">Organization/orgohara</a> &quot;Ohara Pharmaceutical Co., Ltd.&quot;</p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://pmda-approvalandlicenseno/"/>
    <value value="21300AMY00128"/>
  </identifier>
  <subject>🔗 
    <reference value="MedicinalProductDefinition/medprodsimvastatin20"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000072062"/>
    </coding>
    <text value="Marketing Authorisation"/>
  </type>
  <region>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="jp"/>
    </coding>
    <text value="Japan"/>
  </region>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
    </coding>
    <text value="Active"/>
  </status>
  <statusDate value="2002-08-01T13:28:17Z"/>
  <holder>🔗 
    <reference value="Organization/orgohara"/>
  </holder>
</RegulatedAuthorization>